Bavarian Nordic Receives Contract From Janssen As Part Of Ebola Vaccine Regimen

News   Sep 16, 2015

 
Bavarian Nordic Receives Contract From Janssen As Part Of Ebola Vaccine Regimen
 
 
 

RELATED ARTICLES

New Rare Antibody Isolation Strategy

News

A strategy for rapidly isolating rare, naturally occurring antibodies is reported this week. The strategy could aid in developing biological therapeutics and vaccines in the future.

READ MORE

Synthetic Horsepox Virus Could Lead to More Effective Smallpox Vaccine

News

University of Alberta researchers created a new synthetic virus that could lead to the development of a more effective vaccine against smallpox.

READ MORE

New Partnership to Provide Bioanalytical and DMPK Services

News

Concept Life Sciences, the integrated drug discovery, development and analytical services company, and Alderley Analytical, bioanalytical Contract Research Organisation (CRO), today announced they have signed a partnership agreement to provide high-value bioanalytical and DMPK study services.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE